Tag Archives | BIOgraph

Healthcare and Biotech for Relative Safety: ALXN, REGN, OPTR, SGEN

buy Lyrica A Place to Hide from Volatility Today was not as bad as early futures and European markets would portend. The S&P cut its losses to 0.74% and the NASDAQ was down only 0.26%. But as we recommended last month the healthcare sector looks good for relative safety. Drug stocks that pay dividends and large cap […]

Continue Reading